Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nahum Méndez-Sánchez"'
Autor:
Roberto J Herrera-Mercadillo, Misael Uribe, Nahum Méndez-Sánchez, Carlos A. Aguilar-Salinas, Paloma Almeda-Valdes
Publikováno v:
Current Medicinal Chemistry. 26:3613-3619
Metabolic syndrome is a frequent metabolic disorder characterized by obesity and insulin resistance seems to be the main pathophysiological alteration. The goal of treating metabolic syndrome is to reduce the risk of coronary heart disease and the de
Publikováno v:
Current Medicinal Chemistry. 19:4850-4860
Liver fibrosis represents a health problem with significant morbidity and mortality that affects 100 million people worldwide. It is a final pathway to several chronic liver diseases and is characterized by excess collagen and accumulation of extrace
Autor:
Nahum Méndez-Sánchez, Misael Uribe, V. J. Barbero-Becerra, J. J. Santiago-Hernandez, F. A. Villegas-Lopez, Norberto C. Chávez-Tapia
Publikováno v:
Scopus-Elsevier
Metformin is an antidiabetic drug used widely in clinical practice. Its main clinical effect is to reduce blood glucose levels by improving insulin resistance. Nonalcoholic fatty liver disease is characterized by chronic liver damage and can develop
Autor:
Roberto Medina-Santillán, Noberto C. Chavez-Tapia, Daniel Zamora-Valdés, Nahum Méndez-Sánchez, Misael Uribe
Publikováno v:
Current medicinal chemistry. 14(18)
In recent years, there has been an increasing prevalence of obesity and related diseases. This epidemiological change has increased the interest of researchers in the molecular and biochemical pathways involved in the pathogenesis of hepatic and bili